Conference Programme [International Conference on AIDS (16th: 2006: Toronto, Canada)]

Tuesday 15 August
Plenary Session
Theme: Prevention: Proven Approaches and New
Technologies
Venue: Session Room 1, Level 800 (South Building)
There will be a simultaneous transmission
of this session in Session Room 8, Level 100
(North Building) FR ES RU
Time: 08:45 - 10:15
Chairs: Asok Alexander, India
Lennart Hjelmaker, Sweden
Xavier Bertrand (TBC), France
Liviana Calzavara, Canada
TUPL01 Conceptual frameworks and HIV/AIDS
prevention paradigms
Cristina Pimenta, Brazil
Cristina Pimenta is a psychologist by training
at the University of Maryland, has a Master's
Degree in Education from George Mason
University and a PhD in Collective Health from
the Federal University of Rio de Janeiro.
Cristina has been Executive Director of the
Brazilian Interdisciplinary AIDS Association
(ABIA) since 2002 and has published a number
of articles in HIV/AIDS prevention (youth,
women and on HIV/AIDS prevention, harm
reduction). She also has vast experience in
programme implementation and monitoring
of public policies.
Cristina has worked as an international
consultant in the field of HIV/AIDS prevention
for 15 years and was the Head of the
Prevention Unit of the Brazilian National AIDS
Programme from 1996-2000 and again for a
year in 2005-2006.
TUPLO2 Microbicides and other prevention
technologies
Gita Ramjee, South Africa
Professor Gita Ramjee is the Director of the
South African Medical Research Council (MRC)
HIV/AIDS Lead Programme, and Director of
the MRC HIV Prevention Research Unit. Prof.
Ramjee is involved in numerous international
research programmes and clinical trials in
the field of HIV prevention.

TUPLO3

x..

Key Challenge-focused session
~ Working with Youth Services and Issues
All sessions are open to all delegates
Prof. Ramjee is a long-standing contributor
to the International AIDS Conference, having
served as committee member and reviewer
of abstracts. She was also the co-chair of the
recent Microbicides 2006 Conference which
took place in South Africa, and is a track chair
for the upcoming 4th IAS Conference on HIV
Pathogenesis, Treatment and Prevention in
Sydney, Australia, in 2007.
Prof. Ramjee's research interests focus
on HIV prevention and women-initiated
prevention options such as microbicides, as
well as treatment and care research in HIV
positive populations.
Prof. Ramjee received her PhD at the
University of Natal, South Africa in 1994,
and was awarded a Distinguished Visiting
Professorship by the Tamil Nadu Medical
University in India in 2005.
Dynamics of HIV/AIDS vaccine
research: From dream and nightmare to
reality and hope
Frangoise Barre-Sinoussi, France
Professor Frangoise Barre-Sinoussi, PhD,
Director of the Retrovirus Biology Unit,
now re-named "Regulation of Retroviral
Infections" Unit at the Institut Pasteur in
Paris, has been involved in retrovirology
research since the early 1970s. She is
recognised for her contributions to HIV/AIDS
research, in particular for the identification
and characterisation of HIV in the 80s. She
is indeed the first author of the publication
that first reported (in Science in 1980s) the
discovery of a retrovirus, later named HIV, in
a patient at risk of developing AIDS.
In 1988, Frangoise Barr6-Sinoussi became
responsible for her own laboratory at the
Institut Pasteur and initiated research
programmes on viral and host determinants
of HIV/AIDS pathogenesis. Between 1988 and
1998, she was also involved in collaborative
programmes on HIV vaccine research, using
primate models.
Today, the research programmes of her
team are focused on innate regulations of
HIV/SIV infection (intracellular restrictions
of HIV-1 infection and innate immunity, in
particular regulations of T cell activation and
homeostasis resulting from the NK-dendritic
cell interplay).
Frangoise Barr-Sinoussi is author and coauthor of more than 200 original publications
and of more than 120 articles in book reviews.
She has been invited as a speaker to about 250
international meetings and/or conferences.
She has been (and is still) a member of a
number of scientific committees in France and
elsewhere, including scientific committees of

several International AIDS Conferences. She
has also received 10 national or international
awards for her contributions to HIV/AIDS.

-u

Tuesday
Plenary
Session

Afflite
Events
Prgrmm

Prof. Ramjee is the principle investigator on
3 Phase III and 1 Phase IIB microbicide trials,
1 Phase III trial of the vaginal diaphragm
and a trial to test the effectiveness of shortcourse ARV therapy at HIV-1 seroconversion.
With her team of 240 researchers and support
staff, she is involved in the testing of 5 out of
6 microbicide products that have reached this
advanced stage of development.

XVI INTERNATIONAL AIDS CONFERENCE * 13-18 AUGUST 2006 * TORONTO CANADA * CONFERENCE PROGRAMME